Adel K. El‐Naggar

Active 1987–2025

Also published as
Adel K. El Naggar · Adel K. El-Naggar
261
Papers
52,800
Citations
129
h-index
257
i10-index

Citations

Citations per year for Adel K. El‐Naggar1980: 2 citations1990: 5 citations1991: 10 citations1992: 15 citations1993: 14 citations1994: 14 citations1995: 34 citations1996: 47 citations1997: 59 citations1998: 81 citations1999: 130 citations2000: 150 citations2001: 167 citations2002: 176 citations2003: 207 citations2004: 240 citations2005: 257 citations2006: 280 citations2007: 277 citations2008: 264 citations2009: 325 citations2010: 315 citations2011: 350 citations2012: 419 citations2013: 474 citations2014: 502 citations2015: 459 citations2016: 499 citations2017: 521 citations2018: 396 citations2019: 1,497 citations2020: 1,677 citations2021: 1,460 citations2022: 1,112 citations2023: 830 citations2024: 1,124 citations2025: 495 citations2026: 12 citations1981–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,912 citing papers, 31.6% of this breakdownChina: 1,634 citing papers, 8.7% of this breakdownItaly: 1,050 citing papers, 5.6% of this breakdownUnited Kingdom: 1,021 citing papers, 5.5% of this breakdownGermany: 850 citing papers, 4.5% of this breakdownJapan: 710 citing papers, 3.8% of this breakdownCanada: 635 citing papers, 3.4% of this breakdownFrance: 634 citing papers, 3.4% of this breakdownAustralia: 458 citing papers, 2.5% of this breakdownSpain: 451 citing papers, 2.4% of this breakdownIndia: 414 citing papers, 2.2% of this breakdownNetherlands: 406 citing papers, 2.2% of this breakdown
0%31.6%Other 24.2%

Fields

  • Medicine63.7%
  • Biochemistry, Genetics and Molecular Biology27.8%
  • Dentistry3.2%
  • Immunology and Microbiology1.7%
  • Computer Science0.6%
  • Neuroscience0.6%
  • Other2.4%

Topics

  • Head and Neck Cancer Studies4.8%
  • Cancer-related Molecular Pathways3.9%
  • Thyroid Cancer Diagnosis and Treatment3.7%
  • Salivary Gland Tumors Diagnosis and Treatment2.8%
  • RNA modifications and cancer2.2%
  • Cancer Genomics and Diagnostics1.9%
  • Other80.7%

Coauthors

All papers

Open in search
  1. Integrated Genomic Characterization of Papillary Thyroid Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Timothy A. Chan, Amy Y. Chen, Andrew D. Cherniack, Dorothy Cheung, Lynda Chin, Juok Cho, Andy Chu, Eric Chuah, Kristian Cibulskis, Giovanni Ciriello, Amanda Clarke, Gary L. Clayman, Leslie Cope, John A. Copland, Kyle R. Covington, Ludmila Danilova, Tanja M. Davidsen, John A. Demchok, Daniel DiCara, Noreen Dhalla, Rajiv Dhir, Sheliann S. Dookran, Gideon Dresdner, Jonathan Eldridge, Greg Eley, Adel K. El‐Naggar, Stephanie Eng, James A. Fagin, Timothy R. Fennell, Robert L. Ferris, Sheila Fisher, Scott Frazer, Jessica Frick, Stacey Gabriel, Ian Ganly, Jianjiong Gao, Levi A. Garraway, Julie M. Gastier-Foster, Gad Getz, Nils Gehlenborg, Ronald Ghossein, Richard A. Gibbs, Thomas J. Giordano, Karen Gomez-Hernandez, Jonna Grimsby, Benjamin Groß, Ranabir Guin, Angela Hadjipanayis, Hollie A. Harper, D. Neil Hayes, David I. Heiman, James G. Herman, Katherine A. Hoadley, Matan Hofree, Robert A. Holt, Alan P. Hoyle, Franklin W. Huang, Mei Huang, Carolyn M. Hutter, Trey Ideker, Lisa Iype, Anders Jacobsen, Stuart R. Jefferys, Corbin D. Jones, Steven J.M. Jones, Katayoon Kasaian, Electron Kebebew, Fadlo R. Khuri, Jaegil Kim, Roger Kramer and 143 more - Cell 2014 cited by 3,126

  2. Loss of p53 drives neuron reprogramming in head and neck cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2020 cited by 453

  3. Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy

    Authors: , , - Expert Opinion on Therapeutic Targets 2012 cited by 1,035

  4. Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Seungyeul Yoo, Daniel Cui Zhou, Wen-Wei Liang, Michael C. Wendl, Pankaj Vats, Steven A. Carr, D.R. Mani, Zhen Zhang, Jiang Qian, Xi S. Chen, Alexander R. Pico, Pei Wang, Arul M. Chinnaiyan, Karen A. Ketchum, Christopher R. Kinsinger, Ana I. Robles, Eunkyung An, Tara Hiltke, Mehdi Mesri, Mathangi Thiagarajan, Alissa M. Weaver, Andrew G. Sikora, Jan Lubiński, Małgorzata Wierzbicka, Maciej Wiznerowicz, Shankha Satpathy, Michael A. Gillette, George Miles, Matthew J. Ellis, Gilbert S. Omenn, Henry Rodriguez, Emily S. Boja, Saravana M. Dhanasekaran, Li Ding, Alexey I. Nesvizhskii, Adel K. El‐Naggar, Daniel W. Chan, Hui Zhang, Bing Zhang, Anupriya Agarwal, Matthew L. Anderson, Shayan C. Avanessian, Dmitry M. Avtonomov, Oliver F. Bathe, Chet Birger, Michael J. Birrer, Lili M. Blumenberg, William Bocik, Uma Borate, Melissa Borucki, Meghan C. Burke, Shuang Cai, Anna Calinawan, Sandra Cerda, Alyssa Charamut, Lin Chen, Shrabanti Chowdhury, Karl R. Clauser, Houston Culpepper, Tomasz Czernicki, Fulvio D’Angelo, Jacob Day, Stephanie Young, Emek Demir, Fei Ding, Marcin J. Domagalski, Joseph C. Dort, Brian Druker, Elizabeth R. Duffy, Maureen A. Dyer and 102 more - Cancer Cell 2021 cited by 380

  5. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Modern Pathology 2018 cited by 1,125

  6. WHO classification of head and neck tumours

    Authors: , , , , - International Agency for Research on Cancer eBooks 2017 cited by 1,897

  7. SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , E. Joanna Baxter, J Score, Anna Gallì, Matteo Giovanni Della Porta, Erica Travaglino, Michael J. Groves, Sudhir Tauro, Nikhil C. Munshi, Kristina Anderson, Adel K. El‐Naggar, Andrej Fischer, Ville Mustonen, Alan J. Warren, Nicholas C.P. Cross, Anthony R. Green, P. Andrew Futreal, Michael R. Stratton, Peter J. Campbell - New England Journal of Medicine 2011 cited by 1,216

  8. Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ronald Ghossein - JAMA Oncology 2016 cited by 1,384

  9. Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome

    Authors: , , , , , , , , , , , - Cell 2004 cited by 1,086

  10. Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jack A. Taylor, D Neil Hayes, David Malkin, ICGC Breast Cancer Group, ICGC Chronic Myeloid Disorders Group, ICGC Prostate Cancer Group, Christopher S. Foster, Anne Y. Warren, Hayley C. Whitaker, Daniel S. Brewer, Rosalind A. Eeles, Colin Cooper, David E. Neal, Tapio Visakorpi, William B. Isaacs, G. Steven Bova, Adrienne M. Flanagan, P. Andrew Futreal, Andy G. Lynch, Patrick F. Chinnery, Ultan McDermott, Michael R. Stratton, Peter J. Campbell - eLife 2014 cited by 500

  11. Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 cited by 832

  12. Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey N. Myers - Science 2011 cited by 1,702

  13. Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 cited by 138

  14. Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2014 cited by 607

  15. Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma

    Authors: , , , , , , , , , , , , - Journal of Clinical Oncology 2014 cited by 546

  16. Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2019 cited by 210

  17. Highly prevalent TERT promoter mutations in aggressive thyroid cancers

    Authors: , , , , , , , , - Endocrine Related Cancer 2013 cited by 607

  18. An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Genetics 2016 cited by 301

  19. Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets

    Authors: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 140

  20. Integrative Genomic Characterization of Oral Squamous Cell Carcinoma Identifies Frequent Somatic Drivers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2013 cited by 563

  21. Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 245

  22. Characterization of HPV and host genome interactions in primary head and neck cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew Meyerson, Peter J. Park, Lynda Chin, Jonathan G. Seidman, Peter S. Hammerman, Raju Kucherlapati, the Cancer Genome Atlas Network, Adrian Ally, Miruna Balasundaram, İnanç Birol, Reanne Bowlby, Yaron S.N. Butterfield, Rebecca Carlsen, Dean Cheng, Andy Chu, Noreen Dhalla, Ranabir Guin, Robert A. Holt, Steven J.M. Jones, Darlene Lee, Haiyan I. Li, Marco A. Marra, Michael Mayo, Richard A. Moore, Andrew J. Mungall, A. Gordon Robertson, Jacqueline E. Schein, Payal Sipahimalani, Angela Tam, Nina Thiessen, Tina Wong, Alexei Protopopov, Netty Santoso, Semin Lee, Michael Parfenov, Jianhua Zhang, Harshad S. Mahadeshwar, Jiabin Tang, Xiaojia Ren, Sahil Seth, Psalm Haseley, Dong Zeng, Lixing Yang, Andrew W. Xu, Xingzhi Song, Angeliki Pantazi, Christopher A. Bristow, Angela Hadjipanayis, Jonathan G. Seidman, Lynda Chin, Peter J. Park, Raju Kucherlapati, Rehan Akbani, Tod D. Casasent, Wenbin Liu, Yiling Lu, Gordon B. Mills, Thomas Motter, John N. Weinstein, Lixia Diao, Jing Wang, You Hong Fan, Jinze Liu, Kai Wang, J. Todd Auman, Saianand Balu, Tom Bodenheimer, Elizabeth Buda, D. Neil Hayes, Katherine A. Hoadley and 277 more - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 395

  23. p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer

    Authors: , , , , , , , , , , , - Cancer Cell 2012 cited by 330

  24. Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo

    Authors: , , , , , , , , - Science Advances 2024 cited by 45